Maxwell Skor Stock Analyst Profile - Morgan Stanley Research Coverage - Stocknear

Maxwell Skor

Stock Analyst at Morgan Stanley

(3.53)
# 2602
Out of 5,493 analysts
6
Total ratings
Success rate
Average return

5 Stocks

Name Action PT Current % Upside Ratings Updated
INSM Insmed
Maintains: Equal-Weight
126 144
137.03 5.09% 1 Aug 21, 2025
ASND Ascendis Pharma
Assumes: Overweight
250
191.99 30.22% 1 Jul 3, 2025
SANA Sana Biotechnology
Assumes: Overweight
12
3.34 259.28% 1 Jul 3, 2025
TCRX TScan Therapeutics
Assumes: Overweight
10
1.85 440.54% 1 Mar 14, 2025
IVVD Invivyd
Maintains: Overweight
10 4
1.12 216.96% 2 Nov 20, 2024